Pawsey S - Search Results

1

Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).

Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Simon JA, et al. Among authors: pawsey s. Menopause. 2023 Mar 1;30(3):239-246. doi: 10.1097/GME.0000000000002138. Epub 2023 Jan 30. Menopause. 2023. PMID: 36720081 Free PMC article. Clinical Trial.

2

Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.

Trower M, Anderson RA, Ballantyne E, Joffe H, Kerr M, Pawsey S. Trower M, et al. Among authors: pawsey s. Menopause. 2020 May;27(5):498-505. doi: 10.1097/GME.0000000000001500. Menopause. 2020. PMID: 32068688 Free PMC article. Clinical Trial.

3

[No title available]

[No authors listed] [No authors listed] PMID: 32769755

4

To the Editor.

Pawsey S, Simon JA, Anderson RA, Dhillo W, Joffe H, Trower M. Pawsey S, et al. Menopause. 2020 Sep;27(9):1996-1997. doi: 10.1097/GME.0000000000001619. Menopause. 2020. PMID: 32852467 No abstract available.

5

Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women.

Pawsey S, Mills EG, Ballantyne E, Donaldson K, Kerr M, Trower M, Dhillo WS. Pawsey S, et al. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3221-e3234. doi: 10.1210/clinem/dgab108. J Clin Endocrinol Metab. 2021. PMID: 33624806 Free PMC article. Clinical Trial.

6

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons.

Ellis AK, Frankish CW, Armstrong K, Steacy L, Tenn MW, Pawsey S, Hafner RP. Ellis AK, et al. Among authors: pawsey s. J Allergy Clin Immunol. 2020 Feb;145(2):610-618.e9. doi: 10.1016/j.jaci.2019.09.010. Epub 2019 Sep 27. J Allergy Clin Immunol. 2020. PMID: 31568796 Clinical Trial.

7

Safety and tolerability of short-term preventive frovatriptan: a combined analysis.

MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S. MacGregor EA, et al. Among authors: pawsey s. Headache. 2009 Oct;49(9):1298-314. doi: 10.1111/j.1526-4610.2009.01513.x. Headache. 2009. PMID: 19788471 Clinical Trial.

8

Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.

MacGregor EA, Pawsey SP, Campbell JC, Hu X. MacGregor EA, et al. Gend Med. 2010 Apr;7(2):88-108. doi: 10.1016/j.genm.2010.04.006. Gend Med. 2010. PMID: 20435272

9

Off-the-Shelf Gd(NO₃)₃ as an Efficient High-Spin Metal Ion Polarizing Agent for Magic Angle Spinning Dynamic Nuclear Polarization.

Elliott SJ, Duff BB, Taylor-Hughes AR, Cheney DJ, Corley JP, Paul S, Brookfield A, Pawsey S, Gajan D, Aspinall HC, Lesage A, Blanc F. Elliott SJ, et al. Among authors: pawsey s. J Phys Chem B. 2022 Aug 25;126(33):6281-6289. doi: 10.1021/acs.jpcb.2c04184. Epub 2022 Aug 16. J Phys Chem B. 2022. PMID: 35973071 Free PMC article.

10

Racing toward Fast and Effective ¹⁷O Isotopic Labeling and Nuclear Magnetic Resonance Spectroscopy of N-Formyl-MLF-OH and Associated Building Blocks.

Ha M, Nader S, Pawsey S, Struppe J, Monette M, Mansy SS, Boekhoven J, Michaelis VK. Ha M, et al. Among authors: pawsey s. J Phys Chem B. 2021 Nov 4;125(43):11916-11926. doi: 10.1021/acs.jpcb.1c07397. Epub 2021 Oct 25. J Phys Chem B. 2021. PMID: 34694819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page